patient survey

There is a new drug called roflumilast that is being considered by Health Canada for its potential in treating psoriasis.

We want to learn about your experience with psoriasis drugs. If you are a patient or caregiver, we invite you to take a survey we will use to inform advocacy efforts for roflumilast.

It is available in both English and French. Take the short survey here: